• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化伴利尿剂抵抗性腹水患者对单次大量腹腔穿刺放液的心血管、肾脏及神经体液反应

Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.

作者信息

Peltekian K M, Wong F, Liu P P, Logan A G, Sherman M, Blendis L M

机构信息

Department of Medicine, Toronto Hospital, Ontario, Canada.

出版信息

Am J Gastroenterol. 1997 Mar;92(3):394-9.

PMID:9068457
Abstract

OBJECTIVE

Large volume paracentesis is an effective treatment for refractory ascites, but the need for routine infusion of albumin or other volume expanders remains controversial. The aim of this study was to assess the short term effects of a single 5-L paracentesis without albumin replacement on total central blood volume, systemic and renal hemodynamics, sodium homeostasis, and neurohumoral factors.

PATIENTS AND METHODS

Twelve patients with biopsy-proven cirrhosis and tense, diuretic-resistant ascites were studied before and 48 h after a single 5-L paracentesis without albumin infusion. Systemic hemodynamics and total central blood volume were assessed using radionuclide angiography. Glomerular filtration rate and effective renal plasma flow were measured by inulin and para-aminohippurate clearances, respectively. Lithium clearance was used as an index of proximal tubular reabsorption of sodium. In addition, plasma concentrations of neurohumoral factors were determined.

RESULTS

Total central blood volume was 2.41 +/- 0.33 L/m2 (mean +/- SEM) before and 2.34 +/- 0.18 L/m2 48 h after large volume paracentesis (p = 0.76). Similarly, no differences were detected in the cardiac index, glomerular filtration rate, effective renal plasma flow, urinary sodium excretion, hematocrit, plasma renin activity, or concentrations of plasma aldosterone, norepinephrine, or atrial natriuretic factor.

CONCLUSIONS

A single large volume paracentesis without albumin replacement causes no disturbances in systemic and renal hemodynamics 48 h after the procedure. These results suggest that a single 5-L paracentesis without albumin infusion is a safe and satisfactory short term option for the management of patients with cirrhosis and tense, diuretic-resistant ascites.

摘要

目的

大量腹腔穿刺放液是治疗顽固性腹水的有效方法,但常规输注白蛋白或其他扩容剂的必要性仍存在争议。本研究旨在评估单次5升腹腔穿刺放液且不补充白蛋白对总中心血容量、全身及肾脏血流动力学、钠稳态和神经体液因子的短期影响。

患者和方法

对12例经活检证实为肝硬化且有张力性、利尿剂抵抗性腹水的患者,在单次5升腹腔穿刺放液且不输注白蛋白之前及之后48小时进行研究。使用放射性核素血管造影评估全身血流动力学和总中心血容量。分别通过菊粉和对氨基马尿酸清除率测量肾小球滤过率和有效肾血浆流量。锂清除率用作近端肾小管钠重吸收的指标。此外,测定血浆神经体液因子浓度。

结果

大量腹腔穿刺放液前总中心血容量为2.41±0.33升/平方米(均值±标准误),放液后48小时为2.34±0.18升/平方米(p = 0.76)。同样,在心脏指数、肾小球滤过率、有效肾血浆流量、尿钠排泄、血细胞比容、血浆肾素活性或血浆醛固酮、去甲肾上腺素或心房利钠因子浓度方面未检测到差异。

结论

单次大量腹腔穿刺放液且不补充白蛋白在操作后48小时不会引起全身和肾脏血流动力学紊乱。这些结果表明,单次5升腹腔穿刺放液且不输注白蛋白是治疗肝硬化和张力性、利尿剂抵抗性腹水患者的一种安全且令人满意的短期选择。

相似文献

1
Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.肝硬化伴利尿剂抵抗性腹水患者对单次大量腹腔穿刺放液的心血管、肾脏及神经体液反应
Am J Gastroenterol. 1997 Mar;92(3):394-9.
2
Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.Child-Pugh C级肝硬化患者对体位、体育锻炼及腹水治疗的临床和神经体液反应:随机前瞻性试验
Croat Med J. 2003 Apr;44(2):178-86.
3
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.低剂量心房利钠肽在代偿期肝硬化中的心血管和肾脏效应
Am J Gastroenterol. 1997 May;92(5):852-7.
4
Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.
Hepatology. 1995 Sep;22(3):753-8.
5
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.特利加压素与白蛋白治疗肝硬化腹腔穿刺术诱发循环功能障碍的随机对照研究
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):303-7. doi: 10.1111/j.1440-1746.2006.04182.x.
6
Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.肝硬化难治性腹水:容量扩张和血浆心钠素水平升高的作用
Hepatology. 1993 Sep;18(3):519-28.
7
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.预防腹腔穿刺术引起的循环功能障碍:米多君与白蛋白对比。一项随机试点研究。
Liver Int. 2008 Aug;28(7):1019-25. doi: 10.1111/j.1478-3231.2008.01734.x. Epub 2008 Apr 11.
8
Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.对伴有大量腹水和稀释性低钠血症的肝硬化患者进行完全腹腔穿刺放液。
Am J Gastroenterol. 1999 Aug;94(8):2219-23. doi: 10.1111/j.1572-0241.1999.01296.x.
9
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.米多君、奥曲肽、白蛋白及经颈静脉肝内门体分流术用于特定肝硬化合并1型肝肾综合征患者
Hepatology. 2004 Jul;40(1):55-64. doi: 10.1002/hep.20262.
10
Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.口服α-肾上腺素能激动剂米多君对肝硬化腹水患者肾血流动力学和肾功能的急性影响。
Hepatology. 1998 Oct;28(4):937-43. doi: 10.1002/hep.510280407.

引用本文的文献

1
Urine TIMP2.IGFBP7 Reflects Kidney Injury After Moderate Volume Paracentesis in Patients With Ascites: A Randomized Control Study.尿组织金属蛋白酶抑制因子2.胰岛素样生长因子结合蛋白7反映腹水患者中等量腹腔穿刺放液后的肾损伤:一项随机对照研究
JGH Open. 2025 Apr 22;9(4):e70168. doi: 10.1002/jgh3.70168. eCollection 2025 Apr.
2
Serum sodium level is predictive for kidney injury or hyponatremia after modest-volume paracentesis (<5 L) in Asian patients with cirrhosis: A single-centered retrospective observational study.血清钠水平可预测亚洲肝硬化患者少量腹腔穿刺放液术(<5升)后发生肾损伤或低钠血症:一项单中心回顾性观察研究。
Medicine (Baltimore). 2025 Feb 7;104(6):e41420. doi: 10.1097/MD.0000000000041420.
3
Use of albumin infusion for cirrhosis-related complications: An international position statement.
白蛋白输注在肝硬化相关并发症中的应用:一项国际立场声明。
JHEP Rep. 2023 May 5;5(8):100785. doi: 10.1016/j.jhepr.2023.100785. eCollection 2023 Aug.
4
Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites.每日小容量腹腔穿刺放液术与难治性腹水患者的临床并发症。
JAMA Netw Open. 2023 Jul 3;6(7):e2322048. doi: 10.1001/jamanetworkopen.2023.22048.
5
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).奥地利共识:晚期慢性肝病中门静脉高压的诊断与管理(Billroth IV)。
Wien Klin Wochenschr. 2023 Sep;135(Suppl 3):493-523. doi: 10.1007/s00508-023-02229-w. Epub 2023 Jun 26.
6
Hepatorenal syndrome: Current concepts and future perspectives.肝肾综合征:当前概念与未来展望。
Clin Mol Hepatol. 2023 Oct;29(4):891-908. doi: 10.3350/cmh.2023.0024. Epub 2023 Apr 13.
7
Albumin administration in patients with cirrhosis: Current role and novel perspectives.肝硬化患者白蛋白治疗:当前作用与新视角。
World J Gastroenterol. 2022 Sep 7;28(33):4773-4786. doi: 10.3748/wjg.v28.i33.4773.
8
Management of refractory ascites.难治性腹水的处理。
Clin Mol Hepatol. 2023 Jan;29(1):16-32. doi: 10.3350/cmh.2022.0104. Epub 2022 Jun 9.
9
Guidelines on the management of ascites in cirrhosis.肝硬化腹水管理指南。
Gut. 2021 Jan;70(1):9-29. doi: 10.1136/gutjnl-2020-321790. Epub 2020 Oct 16.
10
Reply.回复。
Liver Transpl. 2020 Nov;26(11):1541-1542. doi: 10.1002/lt.25816. Epub 2020 Jul 28.